- Home
- BKR vs TAK Comparison
BKR vs TAK Comparison
Compare BKR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKR
- TAK
- Stock Information
- Founded
- BKR 2016
- TAK 1781
- Country
- BKR United States
- TAK Japan
- Employees
- BKR N/A
- TAK N/A
- Industry
- BKR Metal Fabrications
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- BKR Industrials
- TAK Health Care
- Exchange
- BKR Nasdaq
- TAK Nasdaq
- Market Cap
- BKR 44.5B
- TAK 47.3B
- IPO Year
- BKR N/A
- TAK N/A
- Fundamental
- Price
- BKR $48.41
- TAK $13.44
- Analyst Decision
- BKR Strong Buy
- TAK
- Analyst Count
- BKR 19
- TAK 0
- Target Price
- BKR $52.17
- TAK N/A
- AVG Volume (30 Days)
- BKR 8.1M
- TAK 2.8M
- Earning Date
- BKR 10-23-2025
- TAK 10-30-2025
- Dividend Yield
- BKR 1.90%
- TAK 4.04%
- EPS Growth
- BKR 30.28
- TAK N/A
- EPS
- BKR 2.90
- TAK 0.14
- Revenue
- BKR $27,711,000,000.00
- TAK $29,846,840,032.00
- Revenue This Year
- BKR N/A
- TAK $0.14
- Revenue Next Year
- BKR $3.71
- TAK $0.58
- P/E Ratio
- BKR $16.67
- TAK $190.43
- Revenue Growth
- BKR 1.50
- TAK N/A
- 52 Week Low
- BKR $33.60
- TAK $12.80
- 52 Week High
- BKR $50.93
- TAK $15.69
- Technical
- Relative Strength Index (RSI)
- BKR 56.56
- TAK 32.24
- Support Level
- BKR $46.12
- TAK $12.99
- Resistance Level
- BKR $49.16
- TAK $14.23
- Average True Range (ATR)
- BKR 1.50
- TAK 0.13
- MACD
- BKR 0.20
- TAK -0.04
- Stochastic Oscillator
- BKR 69.18
- TAK 36.44
About BKR Baker Hughes Company
Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.